← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
21 ta ish
Ish: The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane +15
MaqolaOchiq kirish20207 iqtibosABIBedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Francesca Conradie, Tatevik R. Bagdasaryan, Borisov Se +25
MaqolaOchiq kirish20227 iqtibosABIRegimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
Emanuele Pontali, Mario Raviǵlione, Giovanni Battista Migliori
Sharh maqolaOchiq kirish20195 iqtibosABIThe REDCap consortium: Building an international community of software platform partners
Paul A. Harris, Robert J. Taylor, Brenda L. Minor +8
MaqolaOchiq kirish20194 iqtibosABISafety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis
Ilse Tack, Asnake Yohannes Dumicho, Liesbet Ohler +6
MaqolaOchiq kirish20202 iqtibosABITB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis
Catherine Berry, Philipp du Cros, Katherine Fielding +7
MaqolaOchiq kirish20222 iqtibosABI